Survival based on HPV status in patients with unknown primary.

David Hebbelstrup Jensen (654571)
Nora Hedback (5661193)
Lena Specht (584338)
Estrid Høgdall (180454)
Elo Andersen (654572)
Marianne Hamilton Therkildsen (539853)
Lennart Friis-Hansen (4514)
Bodil Norrild (654573)
Christian von Buchwald (539855)

Publication date

November 2014

DOI

10.1371/journal.pone.0110456.g001

Abstract

Kaplan-Meier curves on overall survival (A and B) and progression-free survival (C and D), as stratified based on HPV and p16 staining. The survival differences were all statistically significant, as based on logrank tests (P<0.05).</p

Extracted data

We use cookies to provide a better user experience.

Data Protection

Survival based on HPV status in patients with unknown primary.

David Hebbelstrup Jensen (654571)
Nora Hedback (5661193)
Lena Specht (584338)
Estrid Høgdall (180454)
Elo Andersen (654572)
Marianne Hamilton Therkildsen (539853)
Lennart Friis-Hansen (4514)
Bodil Norrild (654573)
Christian von Buchwald (539855)

Open link

Publication date

November 2014

DOI

10.1371/journal.pone.0110456.g001

Abstract

Extracted data

Lyriane Apolinário de Araújo (5459810)
Adriano Augusto Peclat De Paula (5459816)
Hellen da Silva Cintra de Paula (5459828)
Jessica Enocêncio Porto Ramos (5459825)
Brunna Rodrigues de Oliveira (5459804)
Keila Patrícia Almeida De Carvalho (5459822)
Rafael Alves Guimarães (4526788)
Rita de Cássia Gonçalves de Alencar (5459819)
Eliza Carla Barroso Duarte (5459831)
Silvia Helena Rabelo Santos (5459807)
Vera Aparecida Saddi (5459813)
Megmar Aparecida dos Santos Carneiro (4771524)

June 2018

Survival curve of the patients in relation to HPV positivity and negativity low and high risk.</p

Kaplan-Meier curves for disease-free survival (DFS), disease-specific survival (DSS) and overall survival (OS) in patients with HPV positive oropharyngeal squamous cell carcinoma (OSCC) with known HLA class I expression.

Anders Näsman (167962)
Emilia Andersson (303022)
Linda Marklund (319689)
Nikolaos Tertipis (382917)
Lalle Hammarstedt-Nordenvall (469217)
Per Attner (469218)
Tommy Nyberg (469219)
Giuseppe V. Masucci (469220)
Eva Munck-Wikland (319690)
Torbjörn Ramqvist (167977)
Tina Dalianis (167974)

October 2013

(A) DFS stratified for HCA-2 intensity, (B) DSS stratified for HCA-2 intensity, (C) OS stratified...

Survival presented with Kaplan-Meier curves, and analyzed using the logrank test, for disease-specific survival (DSS) in patients with HPV-positive oropharyngeal squamous cell carcinoma (HPVDNA+ OSCC) with known HLA class I intensity and different treatment regimes.

Anders Näsman (167962)
Emilia Andersson (303022)
Linda Marklund (319689)
Nikolaos Tertipis (382917)
Lalle Hammarstedt-Nordenvall (469217)
Per Attner (469218)
Tommy Nyberg (469219)
Giuseppe V. Masucci (469220)
Eva Munck-Wikland (319690)
Torbjörn Ramqvist (167977)
Tina Dalianis (167974)

October 2013

(A) DSS in HPVDNA+ OSCC with absent HCA-2 intensity stratified for radiotherapy (RT) a...

Survival rates according to HPV-status.

Hirotaka Shinomiya (4663057)
Hitomi Shinomiya (4663054)
Mie Kubo (4663051)
Yuki Saito (230959)
Masafumi Yoshida (4663045)
Mizuo Ando (4663048)
Masanori Teshima (4663042)
Naoki Otsuki (562843)
Naomi Kiyota (562845)
Ryohei Sasaki (562841)
Ken-ichi Nibu (562844)

December 2017

Survival curve with Kaplan-Meier estimates of (a) overall survival and (b) disease specific survi...

Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS) in relation to HPV-16 status.

Andrea Casadei Gardini (509580)
Laura Capelli (509585)
Paola Ulivi (11121)
Massimo Giannini (538695)
Eva Freier (538696)
Stefano Tamberi (538697)
Emanuela Scarpi (382324)
Alassandro Passardi (538698)
Wainer Zoli (11120)
Angela Ragazzini (538699)
Dino Amadori (11130)
Giovanni Luca Frassineti (16187)

March 2014

Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS)...

Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to the high-risk HPV status.

Young-Hoon Joo (482383)
Youn-Soo Lee (482384)
Kwang-Jae Cho (482385)
Jun-Ook Park (482386)
In-Chul Nam (482387)
Chung-Soo Kim (482388)
Sang-Yeon Kim (482389)
Min-Sik Kim (421554)

November 2013

Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to...

Kaplan-Maier estimates of Overall Survival among the 58 HPV-DNA/p16INK4a double positive patients, according to each staging system.

Miren Taberna (5108825)
Marisa Mena (2532727)
Sara Tous (4236952)
Miquel Angel Pavón (5108819)
Marc Oliva (2187229)
Xavier León (5108828)
Jacinto Garcia (5108837)
Marta Guix (5108816)
Rafael Hijano (5108831)
Teresa Bonfill (5108834)
Antón Aguilà (5108822)
Laia Alemany (3919937)
Ricard Mesía (5108840)

April 2018

Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...

Kaplan-Meier curves showing disease free patient survival depending on TSCC HPV status and TILs, and n denotes the number of patients in each stratified group.

Anders Näsman (167962)
Mircea Romanitan (167969)
Cecilia Nordfors (167959)
Nathalie Grün (319685)
Hemming Johansson (319686)
Lalle Hammarstedt (319688)
Linda Marklund (319689)
Eva Munck-Wikland (319690)
Tina Dalianis (167974)
Torbjörn Ramqvist (167977)

February 2013

A) HPV+TSCC and B) HPV−TSCC patients stratified by the number of CD8+<...

Disease-free survival analysis of HPV+ patients (N = 49) compared to HPV- patients (log-rank p< 0.001).

Vicenilma de Andrade Martins (5851469)
Jaqueline Diniz Pinho (5851472)
Antonio Augusto Lima Teixeira Júnior (5851475)
Leudivan Ribeiro Nogueira (5851478)
Fábio França Silva (5851481)
Victor Eduardo Maulen (5851484)
André Salim Khayat (394567)
José de Ribamar Rodrigues Calixto (5851487)
Herikson Araújo Costa (5851490)
Leandra Naira Zambelli Ramalho (162689)
Gyl Eanes Barros Silva (5100281)

October 2018

Disease-free survival analysis of HPV+ patients (N = 49) compared to HPV- patients (log-rank p< 0.00...

Kaplan-Meier curves of disease-specific survival (A) and overall survival (B) according to HPV status in all OPC patients.

Zeyi Deng (663055)
Takayuki Uehara (663056)
Hiroyuki Maeda (663057)
Masahiro Hasegawa (663058)
Sen Matayoshi (663059)
Asanori Kiyuna (663060)
Shinya Agena (663061)
Xiaoli Pan (663062)
Chunlin Zhang (663063)
Yukashi Yamashita (663064)
Minqiang Xie (663065)
Mikio Suzuki (663066)

November 2014

Disease-specific survival and overall survival rates were significantly better in HPV DNA-positiv...

Survival analysis of OPSCC patients according to HPV16 E6/E7 expression in CTCs.

Panagiota Economopoulou (3744895)
George Koutsodontis (6685769)
Margaritis Avgeris (6685772)
Areti Strati (6320390)
Christos Kroupis (3503234)
Ioannis Pateras (4753386)
Euthymios Kirodimos (6685775)
Evangelos Giotakis (6685778)
Ioannis Kotsantis (6685781)
Pavlos Maragoudakis (6685784)
Vassilis Gorgoulis (312713)
Andreas Scorilas (432584)
Evi Lianidou (6685787)
Amanda Psyrri (62257)

May 2019

Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...

Kaplan-Maier estimates of Overall Survival among the 66 HPV-related OPSCC patients, according to each staging system.

Miren Taberna (5108825)
Marisa Mena (2532727)
Sara Tous (4236952)
Miquel Angel Pavón (5108819)
Marc Oliva (2187229)
Xavier León (5108828)
Jacinto Garcia (5108837)
Marta Guix (5108816)
Rafael Hijano (5108831)
Teresa Bonfill (5108834)
Antón Aguilà (5108822)
Laia Alemany (3919937)
Ricard Mesía (5108840)

April 2018

Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...

Kaplan—Meier survival curves of the propensity score-matched cohort.

Eugene Kwon (782087)
Jang-Hee Cho (503441)
Hye Min Jang (503439)
Yon Su Kim (165494)
Shin-Wook Kang (277265)
Chul Woo Yang (277266)
Nam-Ho Kim (277267)
Hyun-Ji Kim (782088)
Jeung-Min Park (782089)
Ji-Eun Lee (782090)
Hee-Yeon Jung (249364)
Ji-Young Choi (488316)
Sun-Hee Park (503442)
Chan-Duck Kim (503443)
Yong-Lim Kim (277264)

August 2015

(A) Survival probability did not significantly differ based on HBV infection (p = 0.37). (...

Kaplan-Maier estimates of Overall Survival among the 83 p16INK4a-positive patients, according to each staging system.

Miren Taberna (5108825)
Marisa Mena (2532727)
Sara Tous (4236952)
Miquel Angel Pavón (5108819)
Marc Oliva (2187229)
Xavier León (5108828)
Jacinto Garcia (5108837)
Marta Guix (5108816)
Rafael Hijano (5108831)
Teresa Bonfill (5108834)
Antón Aguilà (5108822)
Laia Alemany (3919937)
Ricard Mesía (5108840)

April 2018

Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...

Survival curve of the patients in relation to HPV positivity and negativity low and high risk.

Lyriane Apolinário de Araújo (5459810)
Adriano Augusto Peclat De Paula (5459816)
Hellen da Silva Cintra de Paula (5459828)
Jessica Enocêncio Porto Ramos (5459825)
Brunna Rodrigues de Oliveira (5459804)
Keila Patrícia Almeida De Carvalho (5459822)
Rafael Alves Guimarães (4526788)
Rita de Cássia Gonçalves de Alencar (5459819)
Eliza Carla Barroso Duarte (5459831)
Silvia Helena Rabelo Santos (5459807)
Vera Aparecida Saddi (5459813)
Megmar Aparecida dos Santos Carneiro (4771524)

June 2018

Survival curve of the patients in relation to HPV positivity and negativity low and high risk.</p

Anders Näsman (167962)
Emilia Andersson (303022)
Linda Marklund (319689)
Nikolaos Tertipis (382917)
Lalle Hammarstedt-Nordenvall (469217)
Per Attner (469218)
Tommy Nyberg (469219)
Giuseppe V. Masucci (469220)
Eva Munck-Wikland (319690)
Torbjörn Ramqvist (167977)
Tina Dalianis (167974)

October 2013

(A) DFS stratified for HCA-2 intensity, (B) DSS stratified for HCA-2 intensity, (C) OS stratified...

Anders Näsman (167962)
Emilia Andersson (303022)
Linda Marklund (319689)
Nikolaos Tertipis (382917)
Lalle Hammarstedt-Nordenvall (469217)
Per Attner (469218)
Tommy Nyberg (469219)
Giuseppe V. Masucci (469220)
Eva Munck-Wikland (319690)
Torbjörn Ramqvist (167977)
Tina Dalianis (167974)

October 2013

(A) DSS in HPVDNA+ OSCC with absent HCA-2 intensity stratified for radiotherapy (RT) a...

Survival rates according to HPV-status.

Hirotaka Shinomiya (4663057)
Hitomi Shinomiya (4663054)
Mie Kubo (4663051)
Yuki Saito (230959)
Masafumi Yoshida (4663045)
Mizuo Ando (4663048)
Masanori Teshima (4663042)
Naoki Otsuki (562843)
Naomi Kiyota (562845)
Ryohei Sasaki (562841)
Ken-ichi Nibu (562844)

December 2017

Survival curve with Kaplan-Meier estimates of (a) overall survival and (b) disease specific survi...

Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS) in relation to HPV-16 status.

Andrea Casadei Gardini (509580)
Laura Capelli (509585)
Paola Ulivi (11121)
Massimo Giannini (538695)
Eva Freier (538696)
Stefano Tamberi (538697)
Emanuela Scarpi (382324)
Alassandro Passardi (538698)
Wainer Zoli (11120)
Angela Ragazzini (538699)
Dino Amadori (11130)
Giovanni Luca Frassineti (16187)

March 2014

Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS)...

Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to the high-risk HPV status.

Young-Hoon Joo (482383)
Youn-Soo Lee (482384)
Kwang-Jae Cho (482385)
Jun-Ook Park (482386)
In-Chul Nam (482387)
Chung-Soo Kim (482388)
Sang-Yeon Kim (482389)
Min-Sik Kim (421554)

November 2013

Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to...

Kaplan-Maier estimates of Overall Survival among the 58 HPV-DNA/p16INK4a double positive patients, according to each staging system.

Miren Taberna (5108825)
Marisa Mena (2532727)
Sara Tous (4236952)
Miquel Angel Pavón (5108819)
Marc Oliva (2187229)
Xavier León (5108828)
Jacinto Garcia (5108837)
Marta Guix (5108816)
Rafael Hijano (5108831)
Teresa Bonfill (5108834)
Antón Aguilà (5108822)
Laia Alemany (3919937)
Ricard Mesía (5108840)

April 2018

Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...

Kaplan-Meier curves showing disease free patient survival depending on TSCC HPV status and TILs, and n denotes the number of patients in each stratified group.

Anders Näsman (167962)
Mircea Romanitan (167969)
Cecilia Nordfors (167959)
Nathalie Grün (319685)
Hemming Johansson (319686)
Lalle Hammarstedt (319688)
Linda Marklund (319689)
Eva Munck-Wikland (319690)
Tina Dalianis (167974)
Torbjörn Ramqvist (167977)

February 2013

A) HPV+TSCC and B) HPV−TSCC patients stratified by the number of CD8+<...

Disease-free survival analysis of HPV+ patients (N = 49) compared to HPV- patients (log-rank p< 0.001).

Vicenilma de Andrade Martins (5851469)
Jaqueline Diniz Pinho (5851472)
Antonio Augusto Lima Teixeira Júnior (5851475)
Leudivan Ribeiro Nogueira (5851478)
Fábio França Silva (5851481)
Victor Eduardo Maulen (5851484)
André Salim Khayat (394567)
José de Ribamar Rodrigues Calixto (5851487)
Herikson Araújo Costa (5851490)
Leandra Naira Zambelli Ramalho (162689)
Gyl Eanes Barros Silva (5100281)

October 2018

Disease-free survival analysis of HPV+ patients (N = 49) compared to HPV- patients (log-rank p< 0.00...

Kaplan-Meier curves of disease-specific survival (A) and overall survival (B) according to HPV status in all OPC patients.

Zeyi Deng (663055)
Takayuki Uehara (663056)
Hiroyuki Maeda (663057)
Masahiro Hasegawa (663058)
Sen Matayoshi (663059)
Asanori Kiyuna (663060)
Shinya Agena (663061)
Xiaoli Pan (663062)
Chunlin Zhang (663063)
Yukashi Yamashita (663064)
Minqiang Xie (663065)
Mikio Suzuki (663066)

November 2014

Disease-specific survival and overall survival rates were significantly better in HPV DNA-positiv...

Survival analysis of OPSCC patients according to HPV16 E6/E7 expression in CTCs.

Panagiota Economopoulou (3744895)
George Koutsodontis (6685769)
Margaritis Avgeris (6685772)
Areti Strati (6320390)
Christos Kroupis (3503234)
Ioannis Pateras (4753386)
Euthymios Kirodimos (6685775)
Evangelos Giotakis (6685778)
Ioannis Kotsantis (6685781)
Pavlos Maragoudakis (6685784)
Vassilis Gorgoulis (312713)
Andreas Scorilas (432584)
Evi Lianidou (6685787)
Amanda Psyrri (62257)

May 2019

Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...

Kaplan-Maier estimates of Overall Survival among the 66 HPV-related OPSCC patients, according to each staging system.

Miren Taberna (5108825)
Marisa Mena (2532727)
Sara Tous (4236952)
Miquel Angel Pavón (5108819)
Marc Oliva (2187229)
Xavier León (5108828)
Jacinto Garcia (5108837)
Marta Guix (5108816)
Rafael Hijano (5108831)
Teresa Bonfill (5108834)
Antón Aguilà (5108822)
Laia Alemany (3919937)
Ricard Mesía (5108840)

April 2018

Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...

Kaplan—Meier survival curves of the propensity score-matched cohort.

Eugene Kwon (782087)
Jang-Hee Cho (503441)
Hye Min Jang (503439)
Yon Su Kim (165494)
Shin-Wook Kang (277265)
Chul Woo Yang (277266)
Nam-Ho Kim (277267)
Hyun-Ji Kim (782088)
Jeung-Min Park (782089)
Ji-Eun Lee (782090)
Hee-Yeon Jung (249364)
Ji-Young Choi (488316)
Sun-Hee Park (503442)
Chan-Duck Kim (503443)
Yong-Lim Kim (277264)

August 2015

(A) Survival probability did not significantly differ based on HBV infection (p = 0.37). (...

Kaplan-Maier estimates of Overall Survival among the 83 p16INK4a-positive patients, according to each staging system.

Miren Taberna (5108825)
Marisa Mena (2532727)
Sara Tous (4236952)
Miquel Angel Pavón (5108819)
Marc Oliva (2187229)
Xavier León (5108828)
Jacinto Garcia (5108837)
Marta Guix (5108816)
Rafael Hijano (5108831)
Teresa Bonfill (5108834)
Antón Aguilà (5108822)
Laia Alemany (3919937)
Ricard Mesía (5108840)

April 2018

Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...

Survival curve of the patients in relation to HPV positivity and negativity low and high risk.

Lyriane Apolinário de Araújo (5459810)
Adriano Augusto Peclat De Paula (5459816)
Hellen da Silva Cintra de Paula (5459828)
Jessica Enocêncio Porto Ramos (5459825)
Brunna Rodrigues de Oliveira (5459804)
Keila Patrícia Almeida De Carvalho (5459822)
Rafael Alves Guimarães (4526788)
Rita de Cássia Gonçalves de Alencar (5459819)
Eliza Carla Barroso Duarte (5459831)
Silvia Helena Rabelo Santos (5459807)
Vera Aparecida Saddi (5459813)
Megmar Aparecida dos Santos Carneiro (4771524)

June 2018

Survival curve of the patients in relation to HPV positivity and negativity low and high risk.</p

Anders Näsman (167962)
Emilia Andersson (303022)
Linda Marklund (319689)
Nikolaos Tertipis (382917)
Lalle Hammarstedt-Nordenvall (469217)
Per Attner (469218)
Tommy Nyberg (469219)
Giuseppe V. Masucci (469220)
Eva Munck-Wikland (319690)
Torbjörn Ramqvist (167977)
Tina Dalianis (167974)

October 2013

(A) DFS stratified for HCA-2 intensity, (B) DSS stratified for HCA-2 intensity, (C) OS stratified...

Anders Näsman (167962)
Emilia Andersson (303022)
Linda Marklund (319689)
Nikolaos Tertipis (382917)
Lalle Hammarstedt-Nordenvall (469217)
Per Attner (469218)
Tommy Nyberg (469219)
Giuseppe V. Masucci (469220)
Eva Munck-Wikland (319690)
Torbjörn Ramqvist (167977)
Tina Dalianis (167974)

October 2013

(A) DSS in HPVDNA+ OSCC with absent HCA-2 intensity stratified for radiotherapy (RT) a...

Survival based on HPV status in patients with unknown primary.

Abstract

Extracted data

Survival based on HPV status in patients with unknown primary.

Abstract

Extracted data

Related items

Related items